Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Stopped by the sponsor due to discrepancies in the recruitment process.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| University Hospital, Akershus | OTHER |
Not provided
Not provided
Not provided
Not provided
It has previously been reported that men with prostate cancer are 1 ) reduced quality of life after diagnosis and treatment, 2 ) neuroticism increases the reduction in QoL related to treatment side effects, and 3) often have very involved and active spouses who seems to have been handed over / taken over parts of the men's responsibility for their own health. We postulate herein a new hypothesis that the stress level is elevated when harbouring undetected prostate cancer. We will investigate whether those who are diagnosed with prostate cancer already in beforehand have an increased degree of masculine stress ( experience of not living up to their own perception of the ideal man ) and neuroticism in the typology. We will examine different personality and QoL questionnaires for patients with elevated PSA, and compare those whose clinical assessment later reveals prostate cancer, with three control groups: 1) men with elevated PSA who are not diagnosed with prostate cancer, 2) men with normal PSA treated for benign prostate enlargement and 3) patient with substantial risk of colorectal cancer (CRC) who undergo colonoscopy, with regard to increased level of masculine stress and the personality trait neuroticism.
Inclusion criteria:
Men who are being referred as new urological outpatient and meet the following criteria:
Control groups: Men being referred to urological / gastroenterological outpatient clinic, and which meet the following criteria:
Age> 18 years and <75 years
Outcome measures:
Together with statistician look for patterns / covariance in replies from those who are diagnosed with prostate cancer in the questionnaires personality evaluation adapted to normal population (Neo-FFI), gender differentiated stress response questionnaire (MGRSS) and questionnaires related to resilience, relationship and quality of life index, compared with the control groups.
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| MGRSS questionnaire | The profile of the answering patterns will be compared to baseline using psychiatric and statistical evaluation. | 2 years |
| Testosterone | Testosterone at baseline and 2 years will be related to wether the patient has confirmed cancer or not. | 2 years |
| Cholesterol | Cholesterol at baseline and 2 years will be related to wether the patient has confirmed cancer or not. | 2 years |
| Measure | Description | Time Frame |
|---|---|---|
| Vitamin D, Folic acid, White Blood Cells, C-reactive protein (CRP) | Blood values at baseline and 2 years will be related to wether the patient has confirmed cancer or not. | 2 years |
| coffee and green tea consumption |
Not provided
Inclusion Criteria:
Men who be referred a new urological outpatient and satisfy the following:
Control group: Men referred to urological outpatient clinic, and who satisfy the following
Control group: Men first time referred urological / gastroenterological outpatient clinic, and which satisfy the following
-- symptoms that might indicate cancer suspicion in colorectum
Age> 40 years and <75 years
Exclusion criteria:
4 Familial occurrence of prostate cancer (one or more 1st degree relatives with CaP)
Not provided
Not provided
Men referred to urological outdoor department or gastroenterological outdoor department
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Gunn Iren Meling, MD PhD | Helse Stavanger HF | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Akershus University Hospital | Lørenskog | NO-1478 | Norway | |||
| Stavanger University Hospital, urological department |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D011469 | Prostatic Diseases |
| ID | Term |
|---|---|
| D005832 | Genital Diseases, Male |
| D000091662 | Genital Diseases |
| D000091642 | Urogenital Diseases |
| D052801 | Male Urogenital Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Blood samples
The consumption of coffee and green tea will be related to wether the patient has confirmed cancer or not.
| 2 years |
| Stavanger |
| NO-4011 |
| Norway |